|
Digoxin (DIG) is a cardiac drug given to treat patients with congestive heart failure, angina and arrythmias. This drug must be monitored in patients to allow proper dose adjustment and prevent toxicity. Digoxin concentrations should be measured at least eight hours after an oral dose and ideally when concentrations have reached steady state.
READ MORE
AccuBind® ELISA
Available Materials
Item
Description
Price
Qty
Order
Product Specs
Method:
Enzyme Immunoassay, Colormetric
Principle:
Competitive Assay, Streptavidin-Coated Plate
Calibrators:
0, 0.25, 0.5, 1, 2, 4 ng/ml
AccuLite® CLIA
Available Materials
Item
Description
Price
Qty
Order
Product Specs
Method:
Enzyme Immunoassay, Chemiluminescence
Principle:
Competitive Assay, Streptavidin-Coated Plate
Calibrators:
0, 0.25, 0.5, 1, 2, 4 ng/ml
Advisories
September 24, 2010 Advisory:
Monobind has upgraded Digoxin to a HRP-based system which uses a
streptavidin plate. Effective Oct 2010, all shipments will include this
new format. Please see new IFU on ELISA page.
|
|
|